These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3277074)
1. Continuous ambulatory peritoneal dialysis and vitamin D. Rapoport J; Shany S; Chaimovitz C Nephron; 1988; 48(1):1-3. PubMed ID: 3277074 [No Abstract] [Full Text] [Related]
2. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Coburn JW Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845 [No Abstract] [Full Text] [Related]
3. Control of mineral metabolism in CAPD patients. Delmez JA Blood Purif; 1989; 7(2-3):167-80. PubMed ID: 2663036 [TBL] [Abstract][Full Text] [Related]
4. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis. Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D Nephron; 1990; 56(4):353-6. PubMed ID: 2079992 [TBL] [Abstract][Full Text] [Related]
5. Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis. Shany S; Rapoport J; Goligorsky M; Yankowitz N; Zuili I; Chaimovitz C Nephron; 1984; 36(2):111-3. PubMed ID: 6607420 [TBL] [Abstract][Full Text] [Related]
6. [Continuous ambulatory peritoneal dialysis]. Fernández de Castro J; González-Pliego JA; Gordillo-Paniagua G Gac Med Mex; 1982 Oct; 118(10):427-30. PubMed ID: 7160574 [No Abstract] [Full Text] [Related]
7. Current problems in continuous ambulatory peritoneal dialysis. Grant G; Lombard M; Keogh B Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S44-7. PubMed ID: 4082363 [TBL] [Abstract][Full Text] [Related]
9. [Continuous ambulatory peritoneal dialysis for therapy of late-stage kidney failure]. Nakayama M; Kawaguchi Y Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1329-34. PubMed ID: 9745284 [No Abstract] [Full Text] [Related]
10. Vitamin D therapy in CAPD: what is its role? Hutchison AJ; Gokal R Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937 [TBL] [Abstract][Full Text] [Related]
11. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Aloni Y; Shany S; Chaimovitz C Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis. Lin CY; Huang TP Nephron; 1991; 59(1):90-5. PubMed ID: 1944754 [TBL] [Abstract][Full Text] [Related]
13. The spectrum of renal bone disease. Hamdy NA Nephrol Dial Transplant; 1995; 10 Suppl 4():14-8; discussion 37-43. PubMed ID: 7478144 [No Abstract] [Full Text] [Related]
15. Pharmacodynamics of menatetrenone and effects on bone metabolism in continuous ambulatory peritoneal dialysis patients. Sugimoto T; Yamakado M; Matsushita K; Iwamoto T; Tagawa H J Int Med Res; 2002; 30(6):566-75. PubMed ID: 12526283 [TBL] [Abstract][Full Text] [Related]
17. [Bone and joint complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) for more than 3 years]. Dratwa M; Wens R; Collart F; Tielemans C Nephrologie; 1989; 10 Suppl():56-61. PubMed ID: 2812191 [TBL] [Abstract][Full Text] [Related]
18. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis. Buccianti G; Bianchi ML; Valenti G Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771 [TBL] [Abstract][Full Text] [Related]